Adaptyv 🇨🇭 Hiring · 34 open roles ↗
Protein engineering platform automating protein expression, binding characterization and thermostability analysis.
About Adaptyv
Adaptyv Bio offers a protein engineering platform that automates the process of protein expression, binding characterization, and thermostability analysis, enabling rapid validation of protein variants. The platform utilizes state-of-the-art automation and a comprehensive API to streamline experimental workflows and deliver high-quality data within a short turnaround time.
Adaptyv is a Switzerland-based company founded in 2020, now around 2 people. It has raised $51M in disclosed funding.
Founded by Julian Englert (Co-Founder and CEO; previously Xsensio; École Polytechnique Fédérale de Lausanne), Daniel Nakhaee-Zadeh Gutierrez (Co-Founder; previously AlveoliX, Healthcare Technologies Co-operate Foundation (HTCf); EPFL (École polytechnique fédérale de Lausanne)), Moustafa Houmani (Co-Founder and CTO; previously ETHZ, Hult Prize Lebanon; Y Combinator).
Its investors also appear on FundFinder's most-active lists for Series A · Generalist (64 funds), Series A · Consumer (43 funds), Series A · Enterprise Software (41 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Hiring now · 34 live roles, checked daily
Showing the newest 8 · all 34 on their careers page ↗
Series A · Aug 2026
Highland Europe- Highland Europe — Highland Europe is a growth-stage technology fund that invests in European internet, mobile, and software companies. · cheques £5M – £25M